Glycemic variability: adverse clinical outcomes and how to improve it?

Zheng Zhou,Bao Sun,Shiqiong Huang,Chunsheng Zhu,Meng Bian

DOI: https://doi.org/10.1186/s12933-020-01085-6

IF: 8.949

2020-07-04

Cardiovascular Diabetology

Abstract:Glycemic variability (GV), defined as an integral component of glucose homoeostasis, is emerging as an important metric to consider when assessing glycemic control in clinical practice. Although it remains yet no consensus, accumulating evidence has suggested that GV, representing either short-term (with-day and between-day variability) or long-term GV, was associated with an increased risk of diabetic macrovascular and microvascular complications, hypoglycemia, mortality rates and other adverse clinical outcomes. In this review, we summarize the adverse clinical outcomes of GV and discuss the beneficial measures, including continuous glucose monitoring, drugs, dietary interventions and exercise training, to improve it, aiming at better addressing the challenging aspect of blood glucose management.

cardiac & cardiovascular systems,endocrinology & metabolism

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to explore the relationship between glycemic variability (GV) and adverse clinical outcomes, and to discuss how to improve glycemic variability. Specifically, the paper focuses on the following aspects:

1. **Relationship between glycemic variability and macrovascular and microvascular complications in diabetes**:
- Both short - term glycemic variability (such as intraday or inter - day variability) and long - term glycemic variability (such as variability between multiple visits) are associated with an increased risk of macrovascular (such as cardiovascular diseases) and microvascular (such as retinopathy, nephropathy) complications in diabetic patients.

2. **Relationship between glycemic variability and hypoglycemia**:
- Glycemic variability is considered an important indicator for predicting the risk of hypoglycemia, especially for diabetic patients treated with insulin.

3. **Relationship between glycemic variability and mortality**:
- Multiple studies have shown that glycemic variability is not only related to diabetes - related complications and hypoglycemia, but also associated with a higher mortality rate.

4. **Potential beneficial measures**:
- The paper discusses various methods to improve glycemic variability, including continuous glucose monitoring (CGM), drug treatment (such as insulin analogs, SGLT2 inhibitors, GLP - 1 receptor agonists, etc.), dietary interventions (such as low - carbohydrate diets), and exercise training.

Through these discussions, the paper aims to provide scientific basis and practical suggestions for better management of blood glucose in clinical practice.